You are here

Acrotech Biopharma

FDA's oncology office uses advisory committee to spotlight timely accelerated approval confirmation

Fierce Pharma

Wed, 11/15/23 - 11:20 am

accelerated approvals

Acrotech Biopharma

FDA cancels ODAC meeting this week to review two more dangling accelerated approvals — but won't explain why

Endpoints

Tue, 11/30/21 - 11:32 pm

accelerated approvals

Acrotech Biopharma

FDA's cancer drug advisors will review 2 more dangling accelerated approvals for multiple myeloma, leukemia

Endpoints

Thu, 09/23/21 - 10:34 pm

accelerated approvals

Multiple Myeloma

Acrotech Biopharma

Could a lymphoma drug work better against COVID-19 than Gilead's remdesivir?

Fierce Biotech

Sun, 01/3/21 - 04:29 pm

Gilead Sciences

Acrotech Biopharma